According to a market report by Lucintel, the future of the eClinical solutions market looks promising with opportunities in the pharmaceutical & biopharmaceutical companies, contract research organizations, consultancy service companies, medical device manufacturers, hospitals, and academic & research institutes. The global eClinical solutions market is expected to reach an estimated $17.1 billion by 2028 with a CAGR of 12.5% from 2023 to 2028. The major drivers for this market are growing number of clinical trials, increasing requirement for data processing and monitoring, and favourable government support and funding for clinical trials.
In this market, electronic data capture (EDC) & clinical data management systems (CDMS), clinical trial management systems (CTMS), clinical analytics platforms, randomization & trial supply management systems (RTSM), clinical data integration platforms, electronic clinical outcome assessment solutions (eCOA), safety solutions, electronic trial master file (eTMF) systems, electronic consent solutions (eConsent), regulatory information management systems (RIMS) are the major segments of eClinical solutions market by product. Lucintel forecasts that electronic data capture (EDC) & clinical data management systems (CDMS) will remain the largest segment over the forecast period due to the increasing need for data standardisation to meet regulatory requirements and growing R&D expenditure by pharmaceutical companies.
Within this market, contract research organizations is expected to remain the largest segment due to the growing trend for outsourcing clinical trial activities to CROs and increasing usage of eClinical solutions in research activities.
North America will remain the largest region due to the increasing prevalence of chronic diseases, growing government grants to support clinical trials, and continuous product development by eClinical solution providers in the region.
Parexel International, Dassault Systèmes, Clario, Datatrak International, Signant Health, 4G Clinical, MaxisIT, IBM Watson Health, eClinical Solutions, and Veeva Systems are the major suppliers in the global eClinical solutions market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global eClinical solutions market by product, delivery mode, clinical trial, end use, and region. Lucintel has compiled a comprehensive research report entitled “Growth Opportunities in the Global eClinical Solutions Market 2023-2028: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the global eClinical solutions market by product, delivery mode, clinical trial, end use, and region, as follows:
eClinical Solutions Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:
Electronic Data Capture (EDC) & Clinical Data Management Systems (CDMS)
Clinical Trial Management Systems (CTMS)
Clinical Analytics Platforms
Randomization & Trial Supply Management Systems (RTSM)
Clinical Data Integration Platforms
Electronic Clinical Outcome Assessment Solutions (eCOA)
Safety Solutions
Electronic Trial Master File (eTMF) Systems
Electronic Consent Solutions (eConsent)
Regulatory Information Management Systems (RIMS)
Others
eClinical Solutions Market by Delivery Mode [Value ($B) Shipment Analysis from 2017 to 2028]:
Web-Hosted Models
Licensed Enterprise Models
Cloud-Based Models
eClinical Solutions Market by Clinical Trial [Value ($B) Shipment Analysis from 2017 to 2028]:
Phase I
Phase II
Phase III
Phase IV
eClinical Solutions Market by End Use [Value ($B) Shipment Analysis from 2017 to 2028]:
Pharmaceutical & Biopharmaceutical Companies
Contract Research Organizations
Consultancy Service Companies
Medical Device Manufacturers
Hospitals
Academic & Research Institutes
eClinical Solutions Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:
North America
Europe
Asia Pacific
The Rest of the World
This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or email us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. Lucintel offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
This report answers the following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the eClinical solutions market by product (electronic data capture (EDC) & clinical data management systems (CDMS), clinical trial management systems (CTMS), clinical analytics platforms, randomization & trial supply management systems (RTSM), clinical data integration platforms, electronic clinical outcome assessment solutions (eCOA), safety solutions, electronic trial master file (eTMF) systems, electronic consent solutions (eConsent), regulatory information management systems (RIMS), and 0thers), delivery mode (web-hosted models, licensed enterprise models, and cloud-based models), clinical trail (Phase I, Phase II, Phase III, and Phase IV), end use (pharmaceutical & biopharmaceutical companies, contract research organizations, consultancy service companies, medical device manufacturers, hospitals, and academic & research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?